For Generic Manufactures, New Medicare Drug Pricing Demo Is a Dud

 
• By Sarah Karlin-Smith
  
close up of a US $2 bill
CMS announces potential list of generics for proposed Part D demonstration. • Source: Shutterstock

More from Medicare

More from Government Payers